Philippines - English - FDA (Food And Drug Administration)

qualifirst health inc - cefepime (as hydrochloride) - powder for injection im / iv - 1g

Philippines - English - FDA (Food And Drug Administration)

qualifirst health inc - cefepime (as hydrochloride) - powder for injection - 1g

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefepime dihydrochloride monohydrate 1.189 g equivalent to cefepime 1 g - powder for injection - 1 g - active: cefepime dihydrochloride monohydrate 1.189 g equivalent to cefepime 1 g excipient: arginine - adults: cefepime-aft is indicated for the treatment of the indications listed below when caused by susceptible bacteria: · lower respiratory tract infections, including pneumonia and bronchitis · urinary tract infections , both complicated, including pyelonephritis, and uncomplicated infections · skin and skin structure infections · intra-abdominal infections, including peritonitis and biliary tract infections · septicaemia · empiric treatment in febrile neutropenic patients.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - cefepime dihydrochloride monohydrate 2.378 g equivalent to cefepime 2 g - powder for injection - 2 g - active: cefepime dihydrochloride monohydrate 2.378 g equivalent to cefepime 2 g excipient: arginine - adults: cefepime-aft is indicated for the treatment of the indications listed below when caused by susceptible bacteria: · lower respiratory tract infections, including pneumonia and bronchitis · urinary tract infections , both complicated, including pyelonephritis, and uncomplicated infections · skin and skin structure infections · intra-abdominal infections, including peritonitis and biliary tract infections · septicaemia · empiric treatment in febrile neutropenic patients.

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - cefepime dihydrochloride monohydrate 1.1892 g equivalent to cefepime 1g - powder for injection - 1 g - active: cefepime dihydrochloride monohydrate 1.1892 g equivalent to cefepime 1g excipient: arginine - adults: cefepime kabi is indicated for the treatment of the indications listed below when caused by susceptible bacteria: · lower respiratory tract infections, including pneumonia and bronchitis · urinary tract infections , both complicated, including pyelonephritis, and uncomplicated infections · skin and skin structure infections · intra-abdominal infections, including peritonitis and biliary tract infections · septicaemia · empiric treatment in febrile neutropenic patients.

New Zealand - English - Medsafe (Medicines Safety Authority)

fresenius kabi new zealand limited - cefepime dihydrochloride monohydrate 2.3785 g equivalent to cefepime 2g - powder for injection - 2 g - active: cefepime dihydrochloride monohydrate 2.3785 g equivalent to cefepime 2g excipient: arginine - adults: cefepime kabi is indicated for the treatment of the indications listed below when caused by susceptible bacteria: · lower respiratory tract infections, including pneumonia and bronchitis · urinary tract infections , both complicated, including pyelonephritis, and uncomplicated infections · skin and skin structure infections · intra-abdominal infections, including peritonitis and biliary tract infections · septicaemia · empiric treatment in febrile neutropenic patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cefepime -

Australia - English - Department of Health (Therapeutic Goods Administration)

hospira australia pty ltd - cefepime -

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noridem enterprises ltd. - cefepime dihydrochloride monohydrate 1189 mg - eq. cefepime 1000 mg - powder for solution for injection/infusion - 1 g - cefepime dihydrochloride monohydrate 1189 mg - cefepime

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

noridem enterprises ltd. - cefepime dihydrochloride monohydrate 2378 mg - eq. cefepime 2000 mg - powder for solution for injection/infusion - 2 g - cefepime dihydrochloride monohydrate 2378 mg - cefepime